Deuterium metabolic imaging phenotypes mouse glioblastoma heterogeneity through glucose turnover kinetics
Open Access
- 4 March 2025
- journal article
- research article
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Abstract
Glioblastomas are aggressive brain tumors with dismal prognosis. One of the main bottlenecks for developing more effective therapies for glioblastoma stems from their histologic and molecular heterogeneity, leading to distinct tumor microenvironments and disease phenotypes. Effectively characterizing these features would improve the clinical management of glioblastoma. Glucose flux rates through glycolysis and mitochondrial oxidation have been recently shown to quantitatively depict glioblastoma proliferation in mouse models (GL261 and CT2A tumors) using dynamic glucose-enhanced (DGE) deuterium spectroscopy. However, the spatial features of tumor microenvironment phenotypes remain hitherto unresolved. Here, we develop a DGE Deuterium Metabolic Imaging (DMI) approach for profiling tumor microenvironments through glucose conversion kinetics. Using a multimodal combination of tumor mouse models, novel strategies for spectroscopic imaging and noise attenuation, and histopathological correlations, we show that tumor lactate turnover mirrors phenotype differences between GL261 and CT2A mouse glioblastoma, whereas recycling of the peritumoral glutamate-glutamine pool is a potential marker of invasion capacity in pooled cohorts, linked to secondary brain lesions. These findings were validated by histopathological characterization of each tumor, including cell density and proliferation, peritumoral invasion and distant migration, and immune cell infiltration. Our study bodes well for precision neuro-oncology, highlighting the importance of mapping glucose flux rates to better understand the metabolic heterogeneity of glioblastoma and its links to disease phenotypes.Keywords
All Related Versions
Funding Information
- H2020 Marie Skłodowska-Curie Actions (10.3030/844776)
- Fundação para a Ciência e a Tecnologia (10.54499/2021.02777.ceecind/cp1675/ct0003)
- Fundação Champalimaud (internal)
This publication has 75 references indexed in Scilit:
- rWTC‐MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic CellsAdvanced Science, 2024
- A user independent denoising method for x‐nuclei MRI and MRSMagnetic Resonance in Medicine, 2023
- Denoising single MR spectra by deep learning: Miracle or mirage?Magnetic Resonance in Medicine, 2023
- The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1—Key Points of the Fifth Edition and Summary of Imaging Findings on Adult‐Type Diffuse GliomasJournal of Magnetic Resonance Imaging, 2023
- Tensor denoising of multidimensional MRI dataMagnetic Resonance in Medicine, 2022
- Uncertainty in denoising of MRSI using low‐rank methodsMagnetic Resonance in Medicine, 2021
- Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi‐echo bSSFP: A pancreatic cancer investigationMagnetic Resonance in Medicine, 2021
- Perturbation of mouse glioma MRS pattern by induced acute hyperglycemiaNMR in Biomedicine, 2007
- Modeling tracer kinetics in dynamic Gd‐DTPA MR imagingJournal of Magnetic Resonance Imaging, 1997
- The synthesis of soft pulses with a specified frequency responseMagnetic Resonance in Medicine, 1989